Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a New Cardiac Pacemaker

NCT01700244 is registered in ClinicalTrials.gov with Nanostim, Inc. as lead sponsor.

NCT NCT01700244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01700244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a New Cardiac Pacemaker
Lead sponsor
Nanostim, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2012
Completion date
August 31, 2013
Enrollment
36 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation with 2 or 3° av or bifascicular bundle branch (bbb) block, normal sinus rhythm with 2 or 3° av or bbb block, sinus bradycardia with infrequent pauses or unexplained syncope with ep findings